Becton, Dickinson and Company (BDX)
-NYSE 101.22 
0.10(0.10%) 10:57AM EDT - Nasdaq Real Time Price
| Prev Close: | 101.12 |
|---|
| Open: | 101.16 |
|---|
| Bid: | 101.46 x 100 |
|---|
| Ask: | 101.47 x 100 |
|---|
| 1y Target Est: | 97.00 |
|---|
| Beta: | 0.83 |
|---|
| Next Earnings Date: | 2-Aug-13 |
|---|
| Day's Range: | 101.10 - 101.89 |
|---|
| 52wk Range: | 71.56 - 102.42 |
|---|
| Volume: | 198,649 |
|---|
| Avg Vol (3m): | 1,129,020 |
|---|
| Market Cap: | 19.66B |
|---|
| P/E (ttm): | 13.51 |
|---|
| EPS (ttm): | 7.51 |
|---|
| Div & Yield: | 1.98 (1.90%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- FDA Nod for Thoratec ControllerZacks(Mon, May 20)
- PKI Downgraded to UnderperformZacks(Mon, May 20)
- July Options Now Available For Becton, Dickinson And Co. (BDX)at TheStreet(Mon, May 20)
- The Top 35 Dividend Champions With Regard To Long-Term Stock Price Appreciationat Seeking Alpha(Sun, May 19)
- Diversify Into Singapore Dollars And Get 4% Yields With High Quality Baa3 Rated Bondsat Seeking Alpha(Fri, May 17)
- 4 Stocks Driving The Health Services Industry Higherat TheStreet(Fri, May 17)
- Wall Street Transcript Interview with Mark W. Oelschlager, Portfolio Manager at Oak Associates, Ltd.: A Health Sciences Fund with a Long-Term FocusWall Street Transcript(Fri, May 17)
- Zacks Industry Outlook Highlights: Life Technologies, Thermo Fisher Scientific, Bayer, Conceptus and Becton, Dickinson and Co.Zacks(Thu, May 16)
- BECTON DICKINSON & CO FinancialsEDGAR Online Financials(Wed, May 15)
- Portfolio Review: Focused Investor LLCat Seeking Alpha(Wed, May 15)
- Does the Healthcare Industry mean Stability?at Motley Fool(Tue, May 14)
- LipoScience Gives Its Shareholders Chest Painsat Seeking Alpha(Tue, May 14)
- The Best In An Expensive Sectorat Motley Fool(Mon, May 13)
- 5 Stocks Driving The Health Services Industry Higherat TheStreet(Fri, May 10)
- Alere Beats Earnings Est, Turns to ProfitZacks(Fri, May 10)
Key Statistics
| Forward P/E (1 yr): | 16.15 |
|---|
| P/S (ttm): | 2.50 |
|---|
| Ex-Dividend Date: | 06-Mar-13 |
|---|
Analysts
| Annual EPS Est
(Sep-13)
: | 5.74 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.48 |
|---|
| Mean Recommendation*: | 2.9 |
|---|
| PEG Ratio (5 yr expected): | 1.97 |
|---|
Business Summary
Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide.
View More